Buruli ulcer: An epidemiological update from Japan
Open Access
- 30 September 2024
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (1) , 3-10
Abstract
Japan is one of the rare non‐tropical countries with documented cases of Buruli ulcer (BU). Mycobacterium ulcerans subsp. shinshuense has been identified as the causative agent. The first report of BU in Japan dates back to 1982, with sporadic reports thereafter. Recently, the number of cases has been on the increase, and 50 cases (57.7%) are from the past decade alone, out of a total of 87 cases reported to date. Japan's well‐developed healthcare facilities play a crucial role in enabling detailed investigations and providing appropriate treatment for patients, contributing to a favorable prognosis. However, the rarity of the disease results in lack of awareness among healthcare professionals, leading to frequent delays in diagnosis. This article aims to offer an updated overview of BU cases in Japan and to raise awareness of BU among dermatologists and other healthcare professionals in a non‐endemic setting.Keywords
Funding Information
- Japan Agency for Medical Research and Development
- Japan International Cooperation Agency
- Japan Society for the Promotion of Science
This publication has 29 references indexed in Scilit:
- Buruli ulcer caused by Mycobacterium ulcerans subsp. shinshuense: A case reportJournal of Infection and Chemotherapy, 2023
- World Health Organization strategic framework for integrated control and management of skin-related neglected tropical diseases: what does this mean for dermatologists?British Journal of Dermatology, 2022
- Climate Change and Cascading Risks from Infectious DiseaseInfectious Diseases and Therapy, 2022
- Buruli Ulcer in Japan2019
- Buruli Ulcer: a Review of the Current KnowledgeCurrent Tropical Medicine Reports, 2018
- Mapping Biopsy Procedure on Management of Severe Buruli Ulcer Due toMycobacterium ulcerans,SubspeciesshinshuenseJAMA Dermatology, 2014
- Comparative Study of the Sensitivity of Different Diagnostic Methods for the Laboratory Diagnosis of Buruli Ulcer DiseaseClinical Infectious Diseases, 2009
- Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteriaNatural Product Reports, 2008
- A Novel Mycolactone from a Clinical Isolate of Mycobacterium ulcerans Provides Evidence for Additional Toxin Heterogeneity as a Result of Specific Changes in the Modular Polyketide SynthaseChemBioChem, 2005
- First reported case of Mycobacterium ulcerans infection in a patient from ChinaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000